Latest Posts
New IBD Diet Research Brings Hope After Years of Confusion
New research finally validates what IBD patients have long suspected: diet significantly impacts symptoms and disease progression. This breakthrough offers hope and evidence-based guidance for taking control of your IBD journey through informed food choices.
Early Crohn’s Treatment Could Transform Your Disease Journey
New research from the LOVE-CD study reveals that starting biologic treatment within 18 months of Crohn’s diagnosis leads to significantly better outcomes than waiting. This could fundamentally change how we approach early IBD care.
Thanksgiving With IBD: Reclaiming Holiday Joy One Bite at a Time
Thanksgiving with IBD doesn’t have to mean sitting on the sidelines. With thoughtful recipe modifications and smart planning strategies, you can reclaim holiday joy and create new traditions that honor both your gut health and your need for celebration.
Cannabis and Crohn’s: New Study Reveals Unexpected Risks
A new study examining over 4,000 Crohn’s patients reveals that cannabis users experienced higher rates of hospitalizations, surgeries, and disease flares. While cannabis may provide symptom relief, researchers suggest it could mask underlying disease progression, raising important questions about balancing short-term comfort with long-term health outcomes.
New Guidelines Bring Hope to Families Managing Pediatric Crohn’s
New clinical practice guidelines from the Canadian Association of Gastroenterology offer hope for families managing pediatric Crohn’s disease. These evidence-based recommendations provide a clearer roadmap for personalized treatment approaches that prioritize both effective care and quality of life for children with IBD.
Crohn’s Surgery After 60: What New Research Reveals
New European research reveals that older adults with Crohn’s disease actually experience fewer immediate surgical complications than younger patients, challenging common assumptions about age and surgery risk. While long-term considerations remain important, this data offers hope for those over 60 facing difficult treatment decisions.
